Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
Lee M. Greenberger, Larry A. Saltzman, Lore Gruenbaum, et al.
Blood Cancer Discovery (2022) Vol. 3, Iss. 6, pp. 481-489
Open Access | Times Cited: 21

Showing 21 citing articles:

Diagnosis and Treatment of Chronic Lymphocytic Leukemia
Mazyar Shadman
JAMA (2023) Vol. 329, Iss. 11, pp. 918-918
Closed Access | Times Cited: 104
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101983-101983
Open Access | Times Cited: 20
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 542-554
Closed Access | Times Cited: 6
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, et al.
Blood Cancer Discovery (2022) Vol. 4, Iss. 2, pp. 106-117
Open Access | Times Cited: 26
Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines
Yang Xu, Kazuya Masuda, Christine Groso, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 4
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Management of vaccinations in patients with non‐Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S. Heitmann, Tanja Michel, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 69-77
Open Access | Times Cited: 7
Quantifiable blood TCR repertoire components associate with immune aging
Jing Hu, Mingyao Pan, Brett M. Reid, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
Sabine Haggenburg, Quincy Hofsink, Caroline E. Rutten, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 192-197
Open Access | Times Cited: 8
Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2
Bruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Blood Reviews (2023) Vol. 60, pp. 101077-101077
Open Access | Times Cited: 4
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL
Emily Tomasulo, Shira Paul, Rui Mu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 14, pp. 2306-2315
Closed Access | Times Cited: 3
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
PLoS Medicine (2023) Vol. 20, Iss. 6, pp. e1004157-e1004157
Open Access | Times Cited: 2
Quantifiable Blood TCR Repertoire Components Associated with Immune Aging
Jing Hu, Mingyao Pan, Brett M. Reid, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination
Ksenia V. Zornikova, Nataliia O Ivanova, O. A. Aleshina, et al.
Russian journal of hematology and transfusiology (2024) Vol. 69, Iss. 2, pp. 200-216
Open Access
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Two approaches to tackling COVID-19 in patients with blood cancer
Ratna Sari Wijaya, Sean H. Lim
Nature Cancer (2023) Vol. 4, Iss. 1, pp. 5-6
Open Access
Data from Impaired SARS-CoV-2 Variant Neutralization and CD8<sup>+</sup> T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, et al.
(2023)
Open Access
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-Analysis Using GRADE
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top